| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/07/2002 | EP1228051A1 Semicarbazone derivatives and their use as thrombopoietin mimetics |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228045A2 Heterocyclic cytotoxic agents |
| 08/07/2002 | EP1228043A1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1228041A2 Indole derivatives and their use as 5ht2a ligands |
| 08/07/2002 | EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227846A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 08/07/2002 | EP1227845A2 Mixture containing rare earths and use thereof |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227828A1 Viruses for the treatment of cellular proliferative disorders |
| 08/07/2002 | EP1227825A1 Isolation and expansion of human marrow stromal cells |
| 08/07/2002 | EP1227823A2 Methods for inducing (in vivo) proliferation and migration of transplanted progenitor cells in the brain |
| 08/07/2002 | EP1227820A2 Oligosaccharide aldonic acids and their topical use |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227812A2 Topical nasal treatment using desloratadine |
| 08/07/2002 | EP1227810A1 Treating cancer by increasing intracellular malonyl coa levels |
| 08/07/2002 | EP1227808A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/07/2002 | EP1227803A2 Methods and compounds for inhibiting amyloid deposits |
| 08/07/2002 | EP1227800A1 Osmotic controlled release drug delivery device |
| 08/07/2002 | EP1227791A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | EP1227714A1 Method for producing metabolites from plants cultivated in soil-less medium |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 08/07/2002 | EP0986562B1 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
| 08/07/2002 | EP0980379B1 Chimeric oligonucleotides and the use thereof |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | EP0888336B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/07/2002 | EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
| 08/07/2002 | EP0839143B1 Tetralin compounds with mdr activity |
| 08/07/2002 | EP0831856B1 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362967A Modulators for beta-amyloid peptide aggregation comprising D-amino acids |
| 08/07/2002 | CN1362965A cytoplasmic transfer to de-differentiate recipient cells |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362949A 1,5-benzodiazepine derivatives as cck-A receptor agonists |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362881A Inflammatory mediation obtained from atractylodes lancea |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362409A 2-phenoxy pyrimidine derivative and its use in treating disease |
| 08/07/2002 | CN1362261A Health tonic containing rich lucid ganoderma selenium |
| 08/07/2002 | CN1362250A Health tonic for delaying senility and regualting blood lipoid |
| 08/07/2002 | CN1362246A Nano Bupleuric medicine for regulating Shaoyang and it spreparation |
| 08/07/2002 | CN1362243A Nano toxic expelling medicine with five ingredients and its preparation |
| 08/07/2002 | CN1362236A Nano Yueje medicine and its preparation |
| 08/07/2002 | CN1362230A Nano Lemai medicine and its preparation |
| 08/07/2002 | CN1362228A Nano heart fire-clearing away bezoar medicine and its preparation |
| 08/07/2002 | CN1362214A Nano shortcape fleaband medicine and its preparation |
| 08/07/2002 | CN1362210A Nano Puerariae, Scutellariae and Coptidis medicine and its preparation |
| 08/07/2002 | CN1362207A Nano healthy energy restoring agastachis medicine and its preparation |
| 08/07/2002 | CN1362183A Nano Lycii-chrysanthemia-rhemanniae medicine and its preparation |
| 08/07/2002 | CN1362148A Nano meridian passage dredging medicine and its preparation |
| 08/07/2002 | CN1362146A Nano Qingkailing medicine and its preparation |
| 08/07/2002 | CN1362141A Nano Xingxiao bezoar medicine and its preparation |
| 08/07/2002 | CN1362139A Nano Pingxiao medicine and its preparation |
| 08/07/2002 | CN1362138A Nano influenza treating decoction and its preparation |
| 08/07/2002 | CN1362134A Nano blood stasis arthralgia treating medicine and its preparation |
| 08/07/2002 | CN1362132A Nano heart-nourishing biotae medicine and its preparation |
| 08/07/2002 | CN1362131A Nano pus drawing out medicine and its preparation |
| 08/07/2002 | CN1362127A Nano itch stopping garter snake medicine and its preparation |
| 08/07/2002 | CN1362126A Nano wind-evil dispelling and itch stopping medicine and its preparation |
| 08/07/2002 | CN1362123A Nano meridian passage-dredging and blood circulation promoting medicine and its preparation |
| 08/07/2002 | CN1362121A Nano Shangqing medicine and its preparation |
| 08/07/2002 | CN1362120A Nano wound-healing motoginseng medicine and its preparation |
| 08/07/2002 | CN1362116A Nano Chinese flowing quine medicine and its preparation |
| 08/07/2002 | CN1362113A Nano coptidis-goat liver meidcine and its preparation |
| 08/07/2002 | CN1362104A Nano Angelicae Pubescentis and Loranthis medicine and its preparation |
| 08/07/2002 | CN1362103A Nano meridian passage dredging medicine and its preparation |
| 08/07/2002 | CN1362098A Nano antiphlogistic forsythiae medicine and its preparation |
| 08/07/2002 | CN1362091A Nano antiphlogistic bezoar medicine and its preparation |
| 08/07/2002 | CN1362089A Nano sanhuang medicine and its preparation |
| 08/07/2002 | CN1362086A Nano Simiao medicine and its preparation |
| 08/07/2002 | CN1362083A Nano zuogui meidcine and its preparation |
| 08/07/2002 | CN1362082A Nano zhuifengtougu medicine and its preparation |
| 08/07/2002 | CN1362081A Nano tranquilizing cinnabar medicine and its preparation |
| 08/07/2002 | CN1362080A Nano zhengqing Fengtongning medicine and its preparation |
| 08/07/2002 | CN1362079A Nano Yuquan medicine and its preparation |
| 08/07/2002 | CN1088599C Therapeutic compositions comprising antigen or an in vivo generator comprising amino-acid serial compounds |
| 08/07/2002 | CN1088585C Compound active at novel site on receptor-operated calcium channels use full for treatment of neurological disorders and diseases |
| 08/07/2002 | CN1088564C Medicated health tea |
| 08/06/2002 | US6429328 Processes and intermediate compounds for preparing guanidine and amidine derivatives |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/06/2002 | US6429229 Keto acid salts and amine derivatives, and their use for preparing medicines |
| 08/06/2002 | US6429224 Use of taurolidine to treat tumors |
| 08/06/2002 | US6429222 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/06/2002 | US6429221 Inhibitors of tumor necrosis factor; used to treat cachexia, endotoxic shock, and retrovirus replication |
| 08/06/2002 | US6429217 Pharmacological drug combination in vagal-induced asystole |
| 08/06/2002 | US6429214 Inhibitors of bone resorption |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6429209 5-ht3 receptor antagonists such as alosetron to treat nonconstipated female irritable bowel syndrome |
| 08/06/2002 | US6429206 Using agonist of nicotinergic acetylcholine receptors |